A catalog of associations between rare coding variants and COVID-19 outcomes

Jack A. Kosmicki(Broad Institute), Gundula Povysil(Bridgepoint (United States)), Lauren Gurski(Regeneron (United States)), Deepika Sharma(Regeneron (United States)), Xiuwen Zheng(University of Washington), Ashish Yadav(ESI - Post Graduate Institute of Medical Science and Research), Rouel Lanche(Regeneron (United States)), Hyun Min Kang(Regeneron (United States)), Sándor Szalma, Siobhan McCarthy(Regeneron (United States)), Anurag Verma(Teerthanker Mahaveer University), Julie Horowitz(Regeneron (United States)), Kyoko Watanabe(Regeneron (United States)), Shaun T. O’Keeffe(Regeneron (United States)), Giorgio Sirugo(Medical Research Council), Q. Wang(AstraZeneca (United Kingdom)), Xiaodong Bai(Capital Medical University), J. W. Davis(AbbVie (United States)), Aldo Córdova‐Palomera(Takeda (United States)), Adam E. Locke(James S. McDonnell Foundation), Anthony Marcketta(Regeneron (United States)), Olympe Chazara(AstraZeneca (United Kingdom)), Tooraj Mirshahi(Geisinger Medical Center), A. H. Li(Regeneron (United States)), Emily Wong(University of Alabama at Birmingham), Nilanjana Banerjee(Regeneron (United States)), Sahar Esmaeeli(Genomics England), Anne E. Justice(Geisinger Health System), Daniel J. Rader(University of Pennsylvania), Joelle Mbatchou(Field Museum of Natural History), David J. Carey(Geisinger Medical Center), Margaret M. Parker(Johns Hopkins University), Erika Kvikstad(Bristol-Myers Squibb (United States)), X. Chen(Pfizer (United States)), Marylyn D. Ritchie(Medical University of South Carolina), Evan K. Maxwell(Regeneron (United States)), Joshua Backman(Regeneron (United States)), Joseph B. Leader(University of Michigan), Colm O’Dushlaine(Broad Institute), Heiko Runz(Heidelberg University), Yunfeng Huang(Emory University), Sana Khalid(Government College University, Lahore), Alison Mansfield(Regeneron (United States)), Dylan Sun(Regeneron (United States)), Slavé Petrovski(AstraZeneca (United Kingdom)), E. N. Smith(Takeda (United States)), Y-P. Lai(Pfizer (United States)), Joseph D. Szustakowski(Novartis (United States)), Anne O’Neill(International Breast Cancer Study Group), Paul Nioi(Amgen (United States))
medRxiv
November 3, 2020
Cited by 31


Related Papers